Aroa Biosurgery Limited (ASX:ARX)

Aroa Biosurgery Revenue

Aroa Biosurgery had revenue of 44.86M NZD in the half year ending September 30, 2025, with 40.75% growth. This brings the company's revenue in the last twelve months to 90.40M, up 18.40% year-over-year. In the fiscal year ending March 31, 2025, Aroa Biosurgery had annual revenue of 84.70M with 22.63% growth.

• Revenue (ttm): 90.40M NZD
• Revenue Growth: +18.40%
• P/S Ratio: 2.62
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 207.54M AUD

Revenue Chart

* This company reports financials in NZD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	84.70M	15.63M	22.63%
Mar 31, 2024	69.07M	5.71M	9.01%
Mar 31, 2023	63.36M	23.68M	59.68%
Mar 31, 2022	39.68M	17.34M	77.60%
Mar 31, 2021	22.34M	-2.73M	-10.90%

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

May 15, 2026

Data Sources Report a data error